EPI-8207

N/A

Report date: 2023/03/02 16:29:24

NME

Base Information

Drug NameEPI-8207

Drug Alias NameEPI-8207EPI8207

ClassificationSmall molecules > Proteolysis-Targeting Chimera (PROTAC)

Mechanisms of ActionAndrogen Receptor degraders

TargetsAndrogen Receptor

Therapy Area/IndicationsProstatic Neoplasms, Castration-Resistant

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesEssa Pharma Inc

China Registration ClassN/A

Active CompaniesEssa Pharma Inc

Inactive CompaniesN/A

Active IndicationsProstatic Neoplasms, Castration-Resistant

Inactive IndicationsN/A

ATC CodeN/A